TY  - JOUR
AU  - Castellano, Daniel
AU  - Apolo, Andrea B
AU  - Porta, Camillo
AU  - Capdevila, Jaume
AU  - Viteri, Santiago
AU  - Rodriguez-Antona, Cristina
AU  - Martin, Lidia
AU  - Maroto, Pablo
PY  - 2022
DO  - 10.1177/17588359221108691
SN  - 1758-8340
UR  - http://hdl.handle.net/10668/20231
T2  - Therapeutic advances in medical oncology
AB  - Cabozantinib monotherapy is approved for the treatment of several types of solid tumors. Investigation into the use of cabozantinib combined with other therapies is increasing. To understand the evidence in this area, we performed a systematic review...
LA  - en
KW  - cabozantinib
KW  - non-small-cell lung cancer
KW  - renal cell carcinoma
KW  - solid tumor
KW  - tyrosine kinase inhibitor
KW  - vascular endothelial growth factor
TI  - Cabozantinib combination therapy for the treatment of solid tumors: a systematic review.
TY  - research article
VL  - 14
ER  -